Our Business
The capabilities in formulations we’ve built at Celon help us bring new products to our focus markets as we work at making healthcare more accessible. And, our continuously expanding network helps impact lives with every passing day.
Catering to demand from across geographies, Celon’s regulatory affairs team ensures adherence to region-specific regulatory standards and guidelines for approvals in ROW markets from time to time.
Committed to ensuring wellbeing, every formulation we bring from laboratory to market is our attempt to add value…value to patients, value to people and value to the medical fraternity.
INDIA
BUSINESS
THERAPY SEGMENTS
- Cancer Care (Oncology)
Sub Therapy Areas
- Solid Tumor
- Hematology
- Supportive Care
THERAPY SEGMENTS
- Critical Care (ICU Cardiovascular / Anesthesia / Anti-infectives)
Sub Therapy Areas
- Intensive Coronary Care
- Pre/Post-operative Care
For Business Enquiries from India , Please Contact:
BRANDED
INTERNATIONAL
PRODUCT FILINGS
640+
CHANNELS
EXTERNAL DISTRIBUTORS
BUSINESS FOCUS
BRANDED/ TENDER
COUNTRIES PRESENT
40+
FOCUS THERAPIES
ONCOLOGY, CARDIOVASCULAR, ANAESTHESIA, ANTI-INFECTIVES
GROWTH PLANS
ENTERING NEW GEOGRAPHIES IN ROW MARKETS
FOCUS MARKETS
LATAM, AFRICA, CIS AND SEA
For International Business Enquiries, Please Contact:
0
+
INTERNATIONAL REGULATORY APPROVALS
0
+
PRODUCT REGISTRATIONS
CONTRACT MANUFACTURING (CMO)
ONCOLOGY
